On July 9, 2018, FDA approved (PDF, 49 KB) the 2 mg Atropine Auto-Injector manufactured by Rafa Laboratories, Ltd., for the treatment of poisoning by susceptible organophosphorous nerve agents having
Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (CO
By using Twitter’s services you agree to our Cookies Use. We and our partners operate globally and use cookies, including for analytics, personalisation, and ads.CloseLog inSign upSee new TweetsPurita
In response to the shortage of personal protective equipment (PPE) as hospitals and clinics scramble to respond to the COVID-19 pandemic, librarians at Columbia University have released a Guide and De